Cargando…

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations

PURPOSE: Despite discrepant results on clinical utility, several trials are already prospectively randomizing non-small cell lung cancer (NSCLC) patients by ERCC1 status. We aimed to characterize the prognostic and predictive effect of ERCC1 by systematic review and meta-analysis. METHODS: Eligible...

Descripción completa

Detalles Bibliográficos
Autores principales: Hubner, Richard A., Riley, Richard D., Billingham, Lucinda J., Popat, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194810/
https://www.ncbi.nlm.nih.gov/pubmed/22022380
http://dx.doi.org/10.1371/journal.pone.0025164